Everyone with diabetes is at risk of losing vision. Good control of blood glucose, blood pressure and blood lipids as well as timely treatment can reduce the incidence of eye disease and vision loss. Regular eye screening is essential for all those living with diabetes.
Diabetic Retinopathy Barometer
The Diabetic Retinopathy Barometer is the product of unique collaboration of experts from the International Federation on Ageing (IFA), International Diabetes Federation (IDF), International Agency for the Prevention of Blindness (IAPB), supported by Bayer Pharma AG. It is a study of almost 7,000 adults with diabetes and health care professionals from 41 countries – highlights the urgent need for clear patient care pathways and robust, responsive health systems around the world to prevent unnecessary vision loss associated with diabetes.
This research was made possible with support from Bayer Pharma AG. Bayer has funded and facilitated this research, acted as an advisor and will assist in the dissemination of the research findings.
Diabetes Eye Health: A guide for health professionals
The guide was developed by the International Diabetes Federation and the Fred Hollows Foundation, and builds upon the ICO Guidelines for Diabetic Eye Care. This guide encourages and facilitates good diabetes management, early diagnosis and treatment of diabetic eye disease, as well encouraging integration and cooperation across the health system. The primary audience for this document is the broad suite of health professionals who work with people with diabetes.
Print this page
Send by email